Page 74 - Contract Development News Today

TOKYO, April 8, 2022 /PRNewswire/ -- AGC Inc. (hereinafter "AGC"), a Tokyo-based world-leading manufacturer of glass, chemicals, high-tech materials, has decided to expand the facilities of

/PRNewswire/ -- The Global CDMO Market is Segmented by Type (API Development, Manufacturing, Drug Delivery), by Application (Pharmaceutical Company,...

/PRNewswire/ -- AGC Inc. (hereinafter "AGC"), a Tokyo-based world-leading manufacturer of glass, chemicals, high-tech materials, has decided to expand the...

Deals relating to India's socioeconomic impact in the pharmaceutical sector have seen a decrease of 27.3% from H2 2020 to H2 2021.

With the new plant, Sumitomo Chemical plans to strengthen its supply of high-quality active pharmaceutical ingredients (APIs) and intermediates in the background of rising demand for small molecule drugs.

PolyPeptide Group / Key word(s): AGMEGM01.04.2022 / 07:00 PolyPeptide publishes invitation to the annual General Meeting 2022Zug, 1 April 2022 - PolyPeptide Group AG (PolyPeptide), a global leader in peptide custom development and manufacturing, published today the invitation to its first annual General Meeting whic...

Orgenesis (NASDAQ:ORGS – Get Rating) released its quarterly earnings data on Wednesday. The company reported ($0.21) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.15), Fidelity Earnings reports. Orgenesis had a negative net margin of 112.03% and a negative return on equity of 76.79%. Shares of Orgenesis stock opened at $3.47 on […]

AGC Biologics is producing vaccine materials for early-stage trials at its Heidelberg facilities...

Investegate announcements from AGC Biologics, Allergy Therapeutics Selects AGC Biologics to Manufacture Novel Peanut Allergy Vaccine Candidate

This agreement will bring new business to the biotech company, which is expanding its manufacturing capabilities and maintains its identity, brand, and complete teamThe transaction validates